Literature DB >> 17522444

The role of metals in the etiology of Alzheimer's disease.

Ivan Shcherbatykh1, David O Carpenter.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, affecting millions of men and women worldwide. It is characterized by the accumulation of extracellular amyloid-beta (A beta) plaques and neurofibrillary tangles inside neurons and dystrophic neurons. Several risk factors are associated with the early onset and progression of the disease. Although the initiating molecular events are not entirely known, in recent years it has become evident that environmental and/or nutritional factors may play a causal, disruptive, and/or protective role in the development of AD. While a direct causal role for aluminum or other transition metals (copper, zinc, iron) in AD has not yet been definitively demonstrated, epidemiological evidence suggests that elevated levels of these metals in the brain may be linked to the development or progression of AD. This review summarizes studies which implicate a role for several metals in contributing to or causing AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17522444     DOI: 10.3233/jad-2007-11207

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  27 in total

Review 1.  Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics.

Authors:  Kelly M Bakulski; Laura S Rozek; Dana C Dolinoy; Henry L Paulson; Howard Hu
Journal:  Curr Alzheimer Res       Date:  2012-06       Impact factor: 3.498

2.  Bone density and brain atrophy in early Alzheimer's disease.

Authors:  Natalia Loskutova; Robyn A Honea; Eric D Vidoni; William M Brooks; Jeffrey M Burns
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

3.  Photobiomodulation and the brain: a new paradigm.

Authors:  Madison Hennessy; Michael R Hamblin
Journal:  J Opt       Date:  2016-12-14       Impact factor: 2.516

4.  Combining conformational sampling and selection to identify the binding mode of zinc-bound amyloid peptides with bifunctional molecules.

Authors:  Liang Xu; Ke Gao; Chunyu Bao; Xicheng Wang
Journal:  J Comput Aided Mol Des       Date:  2012-07-25       Impact factor: 3.686

5.  Characterization of the internal dynamics and conformational space of zinc-bound amyloid β peptides by replica-exchange molecular dynamics simulations.

Authors:  Liang Xu; Xiaojuan Wang; Xicheng Wang
Journal:  Eur Biophys J       Date:  2013-05-03       Impact factor: 1.733

6.  Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity.

Authors:  Dayanidhi Raman; Snjezana-Zaja Milatovic; Dejan Milatovic; Ryan Splittgerber; Guo-Huang Fan; Ann Richmond
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-17       Impact factor: 4.219

7.  Higher aluminum concentration in Alzheimer's disease after Box-Cox data transformation.

Authors:  Robert Rusina; Radoslav Matěj; Lucie Kašparová; Jaromír Kukal; Pavel Urban
Journal:  Neurotox Res       Date:  2011-05-13       Impact factor: 3.911

8.  Blood Harmane (1-Methyl-9H-Pyrido[3,4-b]indole) and Mercury in Essential Tremor: A Population-Based, Environmental Epidemiology Study in the Faroe Islands.

Authors:  Elan D Louis; Eina H Eliasen; Monica Ferrer; Daniella Iglesias Hernandez; Shahin Gaini; Wendy Jiang; Wei Zheng; Flemming Nielsen; Maria Skaalum Petersen
Journal:  Neuroepidemiology       Date:  2020-01-31       Impact factor: 3.282

Review 9.  Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases.

Authors:  Anna Villar-Piqué; Matthias Schmitz; Niccolò Candelise; Salvador Ventura; Franc Llorens; Inga Zerr
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

10.  Serum zinc in the progression of Alzheimer's disease.

Authors:  Jiang Dong; J David Robertson; William R Markesbery; Mark A Lovell
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.